Obesity and cardiovascular risk: a primer for the clinician. [PDF]
Araiza-Garaygordobil D +2 more
europepmc +1 more source
[Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care]. [PDF]
Samperio-González MA +5 more
europepmc +1 more source
Recent Advances of the Zebrafish Model in the Discovery of Marine Bioactive Molecules. [PDF]
Liu C +6 more
europepmc +1 more source
[Colombian Guideline for the Use of Probiotics in Pediatric Diseases]. [PDF]
Alonso Medina Monroy F +11 more
europepmc +1 more source
Effectiveness of a low-fructose and/or low-sucrose diet in decreasing insulin resistance (DISFRUTE study): study protocol for a randomized controlled trial. [PDF]
Domínguez Coello S +8 more
europepmc +1 more source
[PAPPS Cancer Expert Group. Cancer Prevention Recommendations. 2020 PAPPS update]. [PDF]
Marzo-Castillejo M +5 more
europepmc +1 more source
Development of a sweetened beverage tax, Philippines. [PDF]
Onagan FCC, Ho BLC, Chua KKT.
europepmc +1 more source
Ingesta de fructosa líquida, fetge gras i intolerància a la glucosa
In previous studies, our research group showed that fructose administration (10% w/v) into drinking water during 14 days induces hypertriglyceridemia and fatty liver in male rats. In addition, this 14-day fructose supplementation caused, hyperglycemia, hyperinsulinemia and glucose intolerance in female rats.
openaire +2 more sources
[Cancer prevention recommendations: Update 2024]. [PDF]
Bartolomé-Moreno C +7 more
europepmc +1 more source
Association of fructosamine to indices of dyslipidemia in older adults with type 2 diabetes. [PDF]
Innes KE, Selfe TK, Vishnu A.
europepmc +1 more source

